By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid reported after the close of the market Thursday that its second-quarter revenues increased 35 percent as sales of its clinical systems climbed 53 percent year over year.

The Sunnyvale, Calif.-based molecular diagnostics firm brought in total revenues of $67 million for the three-month period ended June 30, compared to $49.6 million for the second quarter of 2010. It easily beat analysts' consensus estimate for revenues of $61 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.